Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and blood sugar. Most people begin on a low dose and gradually increase over several weeks to find their effective maintenance level. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, allowing you to access this therapy at a predictable monthly cost.
How Semaglutide Dosing Works in Clinical Practice
Semaglutide dosing follows a step-up protocol designed to minimize side effects while building tolerance. Patients typically start at 0.25 mg once weekly, then increase by 0.25 mg weekly over 4 weeks to reach 1.0 mg. This gradual titration allows your body to adapt, and many people experience meaningful weight loss at the 1.0 mg maintenance dose. Some individuals continue increasing to 1.7 mg or 2.4 mg weekly, depending on their response and tolerance.
The dosing timeline is individualized—there's no single correct dose for everyone. Factors like body weight, metabolic health, previous medication response, and genetic variation influence where your optimal dose lands. Rather than jumping directly to maximum doses, the stepwise approach helps identify the lowest effective dose that produces results with manageable side effects. This personalized approach is why some patients stabilize at 1.0 mg while others need higher doses to achieve their goals.
What Is the Average Maintenance Dose of Semaglutide?
Clinical trials show that most patients reach their weight loss goals on maintenance doses between 1.0 mg and 2.4 mg weekly. The 2.0 mg dose became the standard maintenance level in major obesity trials, with participants averaging 15-22% body weight reduction over 68 weeks. However, 'average' does not mean 'right for you'—some people achieve excellent results at 1.0 mg, while others need higher dosing for optimal appetite suppression and metabolic benefit.
Your dose ceiling depends on your unique physiology, genetics, and health status. PlexusDx uses the Precision Peptide Genetic Test to identify variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 therapy. Understanding these genetic pathways helps guide your starting dose and predict whether you're likely to benefit from standard maintenance levels or require personalized adjustments. This insight reduces trial-and-error adjustments and accelerates your path to an effective dose.
Starting Dose vs. Maintenance: Building to Your Target
The starting dose of 0.25 mg is intentionally modest—it's designed to introduce GLP-1 signaling to your system without overwhelming it. Week 2 introduces 0.5 mg, week 3 moves to 0.75 mg, and week 4 reaches the first common maintenance dose of 1.0 mg. From this point, dose escalation depends on your tolerability and weight loss response. If you experience significant nausea or constipation, staying at 1.0 mg may be sufficient; if you're not seeing progress or side effects are minimal, your provider may recommend increasing to 1.7 mg or 2.4 mg.
Skipping the titration phase or accelerating it increases nausea, vomiting, and dehydration risk—none of which support long-term adherence. The 4-week ramp-up period is not just arbitrary; it reflects how long your GI system needs to acclimate to GLP-1 signaling. Many patients who rush this process experience worse side effects and lower satisfaction. PlexusDx supports a structured, evidence-based titration schedule with pharmacy guidance so you progress safely to your personalized maintenance dose.
Compounded Semaglutide vs. Brand-Name Ozempic: Dosing Equivalence
Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient as brand-name Ozempic—the dosing schedules and clinical expectations are identical. The difference lies in price and access: PlexusDx compounded semaglutide starts at $149/month regardless of your dose level, with no insurance requirement and HSA/FSA eligibility. Brand-name Ozempic often costs $900–$1,500 monthly, and many insurance plans apply strict prior authorization or weight-based restrictions.
Dosing equivalence means a 0.25 mg injection of compounded semaglutide delivers the same pharmacological effect as 0.25 mg of Ozempic. Your provider's titration plan remains unchanged, and your dose may increase over time based on your clinical response—not your bank account. PlexusDx's commitment is that 'your dose may need to go up, your price won't,' ensuring affordability throughout your entire weight loss journey, from starting dose through maintenance and any future adjustments.
Genetic Testing and Personalized Dose Prediction
PlexusDx Precision Peptide Genetic Test analyzes 14 peptide-pathway variants, including critical GLP-1 and GLP-2 receptor genes, to predict your individual response to semaglutide dosing. The test identifies genetic markers like GLP1R rs6923761 and GIPR rs1800437 that correlate with dose sensitivity and weight loss magnitude. Patients carrying certain variants may achieve target outcomes at lower doses, reducing side effect burden; others benefit from earlier escalation to higher maintenance levels. This genetic insight personalizes your dosing strategy before you invest time and money in treatment.
The Precision Peptide test also evaluates FTO rs9939609 and MC4R rs17782313 variants, which influence appetite regulation and metabolic rate independently of GLP-1 signaling. Understanding this fuller genetic picture helps your provider optimize your compound formula and dosing schedule. After your first month of treatment, the $99 add-on test transforms your dosing decisions from trial-and-error guessing into precision medicine. Patients with genetic insights often reach their maintenance dose 2–3 weeks faster and report higher satisfaction with their weight loss outcome.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What dose of Ozempic should I start on?
All patients begin at 0.25 mg once weekly, regardless of body weight or prior medication use. This low starting dose reduces nausea risk while your body adapts to GLP-1 signaling. Weekly increases of 0.25 mg over 4 weeks bring you to 1.0 mg, the most common maintenance dose, though some people continue escalating to 1.7 mg or 2.4 mg based on clinical response.
Is 1.0 mg the highest dose of semaglutide?
No. While 1.0 mg is a frequent maintenance dose, the FDA-approved maximum for weight management is 2.4 mg weekly. Most patients achieve significant weight loss between 1.0–2.0 mg, but your provider may recommend higher doses if you tolerate the medication well and need additional appetite suppression or metabolic benefit.
How much does compounded semaglutide cost at each dose level?
PlexusDx compounded semaglutide starts at $149/month flat—this price stays the same whether you're on 0.25 mg or 2.4 mg. Your dose may increase as your treatment progresses, but your monthly cost remains predictable. No insurance is required, and the medication is HSA/FSA eligible.
How long does it take to see weight loss results on semaglutide?
Most people notice reduced appetite within 1–2 weeks of starting semaglutide, though measurable weight loss typically appears after 3–4 weeks. Significant results—5–10% body weight loss—usually emerge by 8–12 weeks of consistent therapy. Weight loss continues to increase as your dose escalates and your body adapts, with most dramatic results appearing after 12–24 weeks at a stable maintenance dose.
Can the PlexusDx Precision Peptide Genetic Test help predict my ideal semaglutide dose?
Yes. The test analyzes GLP1R, GIPR, FTO, and MC4R genetic variants that influence dose sensitivity and weight loss magnitude. Patients with genetic insights often reach their optimal maintenance dose 2–3 weeks faster and achieve better outcomes. The $99 test is available as an add-on after your first month of treatment and provides personalized guidance for your entire semaglutide journey.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Eat Popcorn on Wegovy?
Starting Zepbound: What Dose Do You Begin On?